(NASDAQ: RPID) Rapid Micro Biosystems's forecast annual revenue growth rate of 18.59% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.86%.
Rapid Micro Biosystems's revenue in 2025 is $30,523,000.On average, 6 Wall Street analysts forecast RPID's revenue for 2025 to be $1,484,007,787, with the lowest RPID revenue forecast at $1,398,642,546, and the highest RPID revenue forecast at $1,540,430,399. On average, 6 Wall Street analysts forecast RPID's revenue for 2026 to be $1,802,731,280, with the lowest RPID revenue forecast at $1,715,726,104, and the highest RPID revenue forecast at $1,870,855,047.
In 2027, RPID is forecast to generate $2,310,180,212 in revenue, with the lowest revenue forecast at $2,219,584,909 and the highest revenue forecast at $2,378,126,689.